The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public-and private-sector organizations in their efforts to improve the quality of health care in the United States.
Introduction
Significant variation exists in both the types and definitions of outcome measures used in patient registries, even within the same clinical area. This variation reduces the utility of registries, making it difficult to compare, link, and aggregate data across the spectrum of clinical care and reporting. To address these limitations, the Agency for Healthcare Research and Quality (AHRQ) developed the Outcome Measures Framework (OMF), a conceptual model for classifying outcomes that are relevant to patients and providers across most conditions; it is intended to serve as a content model for developing harmonized outcome measures for specific clinical areas. a AHRQ is assessing the feasibility of using the OMF to develop standardized libraries of outcome measures in five clinical areas, including (1) Atrial fibrillation, (2) Asthma, (3) Depression, (4) Lung cancer, and (5) Lumbar spondylolisthesis.
b These clinical areas represent diverse populations and care settings, different treatment modalities, and varying levels of harmonization. For each clinical area, the relevant registries and observational studies are identified, and registry sponsors, informaticists, and clinical subject matter experts are invited to participate in a registry group that focuses on harmonizing outcome measures through a series of in-person and web-based meetings. A stakeholder group, including payers, patient representatives, Federal partners and health system leaders, is also assembled to discuss challenges and provide feedback on the harmonization effort.
A key goal of this effort is to standardize the definitions of the components that make up the outcome measures, so users can understand the level of comparability between measures across different systems and studies. As a final step in the harmonization process, clinical informaticists map the narrative definitions (generated by the workgroups) to standardized terminologies to produce a library of common data definitions.
This document describes the technical approach used to prepare the Standardized Library of Asthma Outcome Measures workbook. For reference, the narrative definitions for the minimum set of outcome measures produced by the Asthma Workgroup are included in Appendix A. 
Approach to Representing an Outcome Definition
For each measure, the accompanying workbook (Appendix B) contains the narrative definition and recommended reporting period (timeframe), the initial population for measurement (e.g., all asthma patients, all asthma patients ages 12 and older), the outcome focused population (patients who experienced the outcome of interest), and the data criteria and value sets.
Electronic Health Record (EHR) data often will not contain all the requisite components of an outcome definition that would allow for the computational confirmation of that outcome. The approach used for this project is to gather the clinician's assertion of an outcome condition and as much supporting evidence as possible, so that even where the expression logic cannot computationally confirm an outcome, some structured evidence might still be available.
Relationships between events raise a challenge because relationships are often not directly asserted in an EHR. Thus, where possible, relationships have been inferred based on time stamps and intervals. Where this is not possible (e.g., cause of death), the logic requires an asserted relationship.
For each outcome, the following have been defined:
• An object representing the outcome condition itself: In many cases, the only structured data will be an assertion of an outcome, with all the supporting evidence being present in the narrative.
• Fast Healthcare Interoperability Resources (FHIR) for evidence for the outcome: These include labs, diagnostic imaging, etc.
• FHIR for additional relevant events: These might include procedures, encounters, etc.
• Temporal aspects for all events: These allow for inferred relationships.
Approach to Identifying Overlaps
A key goal of this project is to leverage existing resources and build connections across initiatives, where possible. To support that goal, the following sources were searched for overlap:
• https://ecqi.healthit.gov/: Primarily looking for overlapping criteria • https://vsac.nlm.nih.gov/: Primarily looking for overlapping value sets • C-CDA: Primarily looking for overlapping data representations • https://www.nlm.nih.gov/cde/: Primarily looking for overlapping data element definitions Each website has a specific, unique purpose, and data representations vary, so while there are some direct comparisons with similar use cases, there are also important differences both in terms of data structures and use cases. Results of the comparisons are provided below.
• https://ecqi.healthit.gov/; https://vsac.nlm.nih.gov/:
o Asthma-related value sets in VSAC:
 There are 3 Asthma Condition value sets and 1 Asthma Medication value set in VSAC:
•  Reasons for differences include:
• Different use cases.
• +/-inclusion of retired codes.
• Different groups find different codes.
• Drug class ambiguities.
• +/-inclusion on non-billable ICD codes.
• Lack of intensional rules makes comparison difficult.
o eCQMs are based on the National Quality Forum's Quality Data Model, as expressed as HL7 QRDA templates, whereas this project is based on FHIR version 1.8.0 objects. c The HL7 Clinical Quality Improvement committee is actively harmonizing QDM and FHIR resources, and a FHIR-based quality reporting format is expected to be balloted soon.
o VSAC does not at this time provide intensionally-defined value sets. Therefore, comparisons are done based on enumerated lists.
• C-CDA:
o There are no asthma-specific templates or value sets in C-CDA.
• https://www.nlm.nih.gov/cde/:
o We were unable to identify any data elements that laid out specific criteria for any of the asthma outcomes. CDEs generally look for presence/absence of a condition, and may associate a condition with a code system or value set. As a result, there was minimal overlap between any asthma outcome and existing CDEs.
Challenges and Lessons Learned
Some challenges were encountered in translating the text definitions produced by the workgroup into standardized definitions and value sets. Of note, several outcome measures focus on change over time, such as change in medication dosage or change in pulmonary function over a 12-month period. These measures require multiple measurements in the data representations. The workgroup recommended using the first and last measurement within the parameter of "interval of interest" (generally 12 months). For these measures, narrative representations of the changes rather than detailed programming logic are provided.
Related to the outcomes occurring outside of the clinical setting or patient reported activities (e.g., missed work/school days, asthma-related quality of life, medication adherence), condition specific instruments and/or standard terminology representing the instruments may not exist.
Lastly, the workgroup recommended measuring days of work or school missed due to asthma. While missed work or school days may be captured within the EHR setting, there is no reliable way to assert that the missed days are due to asthma (as opposed to another condition).
The project team will apply these lessons learned in subsequent workgroups.
A-1 Clinical Response Exacerbation Exacerbations of asthma are episodes characterized by an increase in symptoms of shortness of breath, cough, wheezing or chest tightness and decrease in lung function, i.e. they represent a change from the patient's usual status that is sufficient to require a change in treatment. Exacerbation includes any of the following: Prescribed systemic steroids (defined as 2 or more days of oral steroids or a steroid injection) or increasing the oral steroid dose from dose at baseline. An asthma-related hospitalization, ED visit, urgent care center visit, or unscheduled office visit requiring prescription of systemic corticosteroids. Documentation by provider of acute asthma exacerbation.
